Our offerings

We are transforming drug development and improving patient outcomes

Our machine learning approaches are rooted in high-quality data

Standard of care modalities

Direct access to longitudinal pathology training data collected in routine practice:

Histopathology data

  • H&E
  • IHC

Omics data

  • DNA sequencing
  • RNA sequencing

Clinical metadata

  • Diagnosis, treatment, outcomes, etc.

“Future of care” modalities

Access to research cohorts and archived tissue that can be used to generate bespoke training data on demand:

DNA

  • Methylomics

RNA

  • scRNA-seq
  • Spatial transcriptomics

Protein

  • mIF
  • Bulk & Spatial Proteomics

We have extensive subject-matter expertise

At Aignostics, good science is at the core of what we do, which is why we’ve built an interdisciplinary team of highly accomplished biologists, pathologists, and machine learning engineers.

In addition to our work with biopharma clients, our team frequently collaborates with external research partners on thought leadership, clinical research, and technical projects that help advance the fields of AI and pathology more broadly.

Selected collaborators

Charité – Universitätsmedizin Berlin is one of the largest university hospitals in Europe. Originally founded in 1710  as a charity hospital, the hospital has been affiliated with many influential scientists in its 300+ year history, including Rudolf Virchow, the founder of cellular pathology and namesake of our first foundation model, RudolfV. Today, Charité Berlin is regarded as one of the premiere hospitals in Europe and sees over 900,000 patients annually.

Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world. It has been ranked number one in the United States for seven consecutive years in U.S. News & World Report's Best Hospitals Honor Roll. With over 150 years of innovation, Mayo Clinic is pioneering an integrated, team-based approach to medicine, including its new focus on digital pathology.

The Ludwig Maximilian University of Munich is a leading public research university in Europe. Originally established as the University of Ingolstadt in 1472 by Duke Ludwig IX of Bavaria-Landshut, it is one of Germany's oldest continually operating universities. More recently, LMU was conferred the title of “University of Excellence” under the German Universities Excellence Initiative for its outstanding work in research and teaching.

Products and services

Products

We offer a range of rigorously developed products for precision medicine that empower your organization to generate valuable insights for drug development.

Pathology Foundation Models

Leverage our foundation models to generate embeddings for model training or develop custom downstream applications for your pathology workflows.

Aignostics Atlas Product Series

Atlas H&E-TME is a comprehensive tumor microenvironment profiling application that was built using our leading foundation model.

Services

We offer custom services for complex image and data analysis from early drug discovery through regulated clinical applications.

Target & Biomarker Discovery

Generate bespoke, multimodal datasets to holistically identify new drug targets and biomarkers.

Translational Research

Measure complex biomarkers and predict expression patterns accurately and scalably across data modalities.

Digital Diagnostics

Refine proof-of-concept models into validated, efficacious clinical tools for prospective use in the real world.

Unlock the power of your data.

Stay connected with us and be the first to learn about how we’re shaping the future of medicine.